Patents by Inventor Miwa KUWAHARA

Miwa KUWAHARA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240053338
    Abstract: An object of the present invention is to provide: a monoclonal antibody that makes it possible that adenovirus contained in a test specimen is detected and measured rapidly, simply, and with high-sensitivity; and an immunoassay for adenovirus and an immunoassay device therefor, for both of which the monoclonal antibody is used. The present invention provides: a monoclonal antibody or an antigen-binding fragment thereof, including heavy chains CDR1 to CDR3 as shown in the following (a) to (c) and a light chain CDR1 as shown in the following (d); and an immunoassay and an immunoassay device, for both of which the monoclonal antibody or the antigen-binding fragment thereof is used; (a) a heavy chain CDR1 composed of an amino acid sequence containing NY; (b) a heavy chain CDR2 composed of an amino acid sequence containing SN; (c) a heavy chain CDR3 composed of an amino acid sequence containing SYY and DY; and (d) a light chain CDR1 composed of an amino acid sequence containing NG.
    Type: Application
    Filed: April 15, 2021
    Publication date: February 15, 2024
    Applicant: DENKA COMPANY LIMITED
    Inventors: Takashi MIYAZAWA, Miwa KUWAHARA
  • Publication number: 20230288418
    Abstract: An object of the present invention is to provide: a monoclonal antibody that makes it possible that adenovirus contained in a test specimen is detected and measured rapidly, simply, and with high-sensitivity; and an immunoassay for adenovirus and an immunoassay device therefor, for both of which the monoclonal antibody is used. The present invention provides: a monoclonal antibody or an antigen-binding fragment thereof, which undergoes antigen-antibody reaction with a hexon trimer of adenovirus; and an immunoassay and an immunoassay device that are used with the monoclonal antibody.
    Type: Application
    Filed: April 15, 2021
    Publication date: September 14, 2023
    Applicant: Denka Company Limited
    Inventors: Takashi MIYAZAWA, Miwa KUWAHARA
  • Publication number: 20230273190
    Abstract: An object is to strongly suppress a false negative reaction and a false positive reaction, which cannot be sufficiently suppressed by a conventional method, in detection of an antigen such as a virus, a bacterium, or a protein to be detected in a specimen originated from a body fluid such as a nasal swab specimen, a nasal aspirate specimen, a nasal wash specimen, a blown snot specimen, a pharyngeal swab specimen, or a saliva specimen with a detection reagent utilizing an antigen-antibody reaction or a reaction between substances interacting with each other. The present invention provides a test reagent for detecting a target substance in a specimen by utilizing an antigen-antibody reaction or a binding reaction between substances interacting with each other, comprising a specimen extracting solution containing a chelating agent.
    Type: Application
    Filed: July 21, 2021
    Publication date: August 31, 2023
    Applicant: Denka Company Limited
    Inventors: Eriko YOSHIZAWA, Yuki SHINOHARA, Shino MURAMATSU, Miwa KUWAHARA
  • Publication number: 20230176056
    Abstract: An object of the present invention is to provide: a monoclonal antibody that makes it possible that adenovirus contained in a test specimen is detected and measured rapidly, simply, and with high-sensitivity; and an immunoassay for adenovirus and an immunoassay device therefor, for both of which the monoclonal antibody is used. The present invention provides: a monoclonal antibody or an antigen-binding fragment thereof, which undergoes antigen-antibody reaction with each subtype of adenovirus: type 1, type 2, type 3, type 4, type 5, type 6, type 7 type 8, type 11, type 19, type 31, type 37, type 53, type 54, type 56, type 64, type 79, type 81, and type 85; and an immunoassay and an immunoassay device, for both of which the monoclonal antibody or an antigen-binding fragment thereof is used.
    Type: Application
    Filed: April 15, 2021
    Publication date: June 8, 2023
    Applicant: DENKA COMPANY LIMITED
    Inventors: Takashi MIYAZAWA, Miwa KUWAHARA
  • Publication number: 20230176055
    Abstract: An object of the present invention is to provide: a monoclonal antibody that makes it possible that adenovirus contained in a test specimen is detected and measured rapidly, simply, and with high-sensitivity; and an immunoassay for adenovirus and an immunoassay device therefor, for both of which the monoclonal antibody is used. The present invention provides: a monoclonal antibody or an antigen-binding fragment thereof, which undergoes antigen-antibody reaction with a polypeptide having the sequence of the 21st to 944th amino acids in the amino acid sequence of SEQ ID NO: 1; and an immunoassay and an immunoassay device, for both of which the monoclonal antibody or an antigen-binding fragment thereof is used.
    Type: Application
    Filed: April 15, 2021
    Publication date: June 8, 2023
    Applicant: Denka Company Limited
    Inventors: Takashi MIYAZAWA, Miwa KUWAHARA
  • Publication number: 20230002479
    Abstract: Provided are an anti-RS virus antibody with high sensitivity and a test reagent using the antibody. An anti-RS virus N protein monoclonal antibody, comprising a heavy chain variable region consisting of the amino acid sequence as set forth in SEQ ID NO: 1, and a light chain variable region consisting of the amino acid sequence as set forth in SEQ ID NO: 2, 3 or 4, or an antigen-binding fragment thereof.
    Type: Application
    Filed: November 11, 2020
    Publication date: January 5, 2023
    Applicant: Denka Company Limited
    Inventor: Miwa KUWAHARA
  • Publication number: 20230003724
    Abstract: Provided are a highly-sensitive antibody and a test reagent using the antibody. A method for detecting an analyte according to an immunoassay method, using a carrier on which an antigen, an antibody or an antigen-binding fragment thereof is immobilized, wherein the analyte is detected with increasing detection sensitivity by using a carrier to which an antigen, an antibody or an antigen-binding fragment thereof was immobilized by adding disaccharide and sugar alcohol to a solution comprising an antigen, an antibody or an antigen-binding fragment thereof.
    Type: Application
    Filed: December 11, 2020
    Publication date: January 5, 2023
    Applicant: Denka Company Limited
    Inventor: Miwa KUWAHARA
  • Publication number: 20220403010
    Abstract: Provided are an anti-RS virus antibody with high sensitivity and a test reagent using the antibody. An anti-RS virus N protein monoclonal antibody or an antigen-binding fragment thereof, which is characterized in that it reacts with peptides consisting of the amino acid sequences as set forth in, at least, SEQ ID NOs: 30, 39, 40, 69, 70, 74, 75, 83, 84, 100, 101, and 113, among 127 peptide spots produced based on the amino acid sequence of the N protein of an RS virus.
    Type: Application
    Filed: November 11, 2020
    Publication date: December 22, 2022
    Applicant: Denka Company Limited
    Inventor: Miwa KUWAHARA
  • Publication number: 20190101532
    Abstract: Disclosed are an immunochromatographic test device which allows a target substance to be detected or quantified more rapidly and sensitively than conventional methods, and a method of forming a sample addition part of the test device. The method of forming a sample addition part of the immunochromatographic test device includes applying a surfactant that is in white powder form under normal conditions, such as sodium deoxycholate, to the sample addition part and drying it. The immunochromatographic test device includes the sample addition part formed by the method.
    Type: Application
    Filed: March 23, 2016
    Publication date: April 4, 2019
    Applicant: DENKA SEIKEN CO., LTD.
    Inventors: Yuki SHINOHARA, Miwa KUWAHARA, Hiroshi AKITA, Takashi MIYAZAWA